JAGX (STOCKS)
Jaguar Health, Inc.
$0.583900
-0.023100 (-3.81%)
Prev close: $0.607000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Lisa A. Conte
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.23M
- Employees
- 49
- P/E (TTM)
- -0.02
- P/B (TTM)
- 0.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-6.28 | $-5.18 | -1.0984 | -21.20% |
|
Jun 2025 (Q2)
|
$-10.26 | $-7.27 | -2.9874 | -41.08% |
|
Mar 2025 (Q1)
|
$-16.70 | $-18.36 | +1.6600 | +9.04% |
|
Dec 2024 (Q4)
|
$-0.34 | $-18.87 | +18.5300 | +98.20% |
Financial Statements
| Revenues | $11.79M |
| Benefits Costs and Expenses | $52.82M |
| Cost Of Revenue | $2.13M |
| Costs And Expenses | $44.61M |
| Gross Profit | $9.65M |
| Operating Expenses | $42.48M |
| Research and Development | $15.19M |
| Other Operating Expenses | $27.29M |
| Operating Income/Loss | -$32.82M |
| Income/Loss Before Equity Method Investments | -$40.86M |
| Income/Loss From Continuing Operations After Tax | -$41.04M |
| Income/Loss From Continuing Operations Before Tax | -$41.04M |
| Income/Loss From Equity Method Investments | -$180.00K |
| Interest Expense, Operating | -$175.00K |
| Net Income/Loss | -$41.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$745.00K |
| Net Income/Loss Attributable To Parent | -$40.29M |
| Net Income/Loss Available To Common Stockholders, Basic | -$40.29M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.58 |
| Diluted Earnings Per Share | -$2.58 |
| Basic Average Shares | 1,448,410 |
| Diluted Average Shares | 1,448,410 |
| Assets | $49.47M |
| Current Assets | $29.40M |
| Inventory | $10.63M |
| Other Current Assets | $18.77M |
| Noncurrent Assets | $20.07M |
| Fixed Assets | $483.00K |
| Intangible Assets | $17.29M |
| Other Non-current Assets | $2.30M |
| Liabilities | $45.11M |
| Current Liabilities | $36.12M |
| Accounts Payable | $8.44M |
| Other Current Liabilities | $27.68M |
| Noncurrent Liabilities | $8.99M |
| Equity | $4.36M |
| Equity Attributable To Noncontrolling Interest | -$1.27M |
| Equity Attributable To Parent | $5.63M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $49.47M |
| Net Cash Flow From Operating Activities | -$26.02M |
| Net Cash Flow From Operating Activities, Continuing | -$26.02M |
| Net Cash Flow From Investing Activities | -$269.00K |
| Net Cash Flow From Investing Activities, Continuing | -$269.00K |
| Net Cash Flow From Financing Activities | $16.71M |
| Net Cash Flow From Financing Activities, Continuing | $16.71M |
| Net Cash Flow | -$9.58M |
| Net Cash Flow, Continuing | -$9.58M |
| Comprehensive Income/Loss | -$41.20M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$754.00K |
| Comprehensive Income/Loss Attributable To Parent | -$40.45M |
| Other Comprehensive Income/Loss | -$162.00K |